BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 20164919)

  • 1. Signatures of mutation and selection in the cancer genome.
    Bignell GR; Greenman CD; Davies H; Butler AP; Edkins S; Andrews JM; Buck G; Chen L; Beare D; Latimer C; Widaa S; Hinton J; Fahey C; Fu B; Swamy S; Dalgliesh GL; Teh BT; Deloukas P; Yang F; Campbell PJ; Futreal PA; Stratton MR
    Nature; 2010 Feb; 463(7283):893-8. PubMed ID: 20164919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of homozygous deletions in human cancer genomes.
    Cox C; Bignell G; Greenman C; Stabenau A; Warren W; Stephens P; Davies H; Watt S; Teague J; Edkins S; Birney E; Easton DF; Wooster R; Futreal PA; Stratton MR
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4542-7. PubMed ID: 15761058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
    Cheng J; Demeulemeester J; Wedge DC; Vollan HKM; Pitt JJ; Russnes HG; Pandey BP; Nilsen G; Nord S; Bignell GR; White KP; Børresen-Dale AL; Campbell PJ; Kristensen VN; Stratton MR; Lingjærde OC; Moreau Y; Van Loo P
    Nat Commun; 2017 Oct; 8(1):1221. PubMed ID: 29089486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncological relevance of fragile sites in cancer.
    Simpson BS; Pye H; Whitaker HC
    Commun Biol; 2021 May; 4(1):567. PubMed ID: 33980983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive catalogue of somatic mutations from a human cancer genome.
    Pleasance ED; Cheetham RK; Stephens PJ; McBride DJ; Humphray SJ; Greenman CD; Varela I; Lin ML; Ordóñez GR; Bignell GR; Ye K; Alipaz J; Bauer MJ; Beare D; Butler A; Carter RJ; Chen L; Cox AJ; Edkins S; Kokko-Gonzales PI; Gormley NA; Grocock RJ; Haudenschild CD; Hims MM; James T; Jia M; Kingsbury Z; Leroy C; Marshall J; Menzies A; Mudie LJ; Ning Z; Royce T; Schulz-Trieglaff OB; Spiridou A; Stebbings LA; Szajkowski L; Teague J; Williamson D; Chin L; Ross MT; Campbell PJ; Bentley DR; Futreal PA; Stratton MR
    Nature; 2010 Jan; 463(7278):191-6. PubMed ID: 20016485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines.
    Shann YJ; Cheng C; Chiao CH; Chen DT; Li PH; Hsu MT
    Genome Res; 2008 May; 18(5):791-801. PubMed ID: 18256232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Distinct Categories of Focal Deletions in Cancer Genomes.
    Rajaram M; Zhang J; Wang T; Li J; Kuscu C; Qi H; Kato M; Grubor V; Weil RJ; Helland A; Borrenson-Dale AL; Cho KR; Levine DA; Houghton AN; Wolchok JD; Myeroff L; Markowitz SD; Lowe SW; Zhang M; Krasnitz A; Lucito R; Mu D; Powers RS
    PLoS One; 2013; 8(6):e66264. PubMed ID: 23805207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
    Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
    Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
    Mestre-Escorihuela C; Rubio-Moscardo F; Richter JA; Siebert R; Climent J; Fresquet V; Beltran E; Agirre X; Marugan I; Marín M; Rosenwald A; Sugimoto KJ; Wheat LM; Karran EL; García JF; Sanchez L; Prosper F; Staudt LM; Pinkel D; Dyer MJ; Martinez-Climent JA
    Blood; 2007 Jan; 109(1):271-80. PubMed ID: 16960149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors.
    Robbins CM; Tembe WA; Baker A; Sinari S; Moses TY; Beckstrom-Sternberg S; Beckstrom-Sternberg J; Barrett M; Long J; Chinnaiyan A; Lowey J; Suh E; Pearson JV; Craig DW; Agus DB; Pienta KJ; Carpten JD
    Genome Res; 2011 Jan; 21(1):47-55. PubMed ID: 21147910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common chromosomal fragile site FRA16D mutation in cancer cells.
    Finnis M; Dayan S; Hobson L; Chenevix-Trench G; Friend K; Ried K; Venter D; Woollatt E; Baker E; Richards RI
    Hum Mol Genet; 2005 May; 14(10):1341-9. PubMed ID: 15814586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of somatic mutation in human cancer genomes.
    Greenman C; Stephens P; Smith R; Dalgliesh GL; Hunter C; Bignell G; Davies H; Teague J; Butler A; Stevens C; Edkins S; O'Meara S; Vastrik I; Schmidt EE; Avis T; Barthorpe S; Bhamra G; Buck G; Choudhury B; Clements J; Cole J; Dicks E; Forbes S; Gray K; Halliday K; Harrison R; Hills K; Hinton J; Jenkinson A; Jones D; Menzies A; Mironenko T; Perry J; Raine K; Richardson D; Shepherd R; Small A; Tofts C; Varian J; Webb T; West S; Widaa S; Yates A; Cahill DP; Louis DN; Goldstraw P; Nicholson AG; Brasseur F; Looijenga L; Weber BL; Chiew YE; DeFazio A; Greaves MF; Green AR; Campbell P; Birney E; Easton DF; Chenevix-Trench G; Tan MH; Khoo SK; Teh BT; Yuen ST; Leung SY; Wooster R; Futreal PA; Stratton MR
    Nature; 2007 Mar; 446(7132):153-8. PubMed ID: 17344846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation.
    Lucito R; Healy J; Alexander J; Reiner A; Esposito D; Chi M; Rodgers L; Brady A; Sebat J; Troge J; West JA; Rostan S; Nguyen KC; Powers S; Ye KQ; Olshen A; Venkatraman E; Norton L; Wigler M
    Genome Res; 2003 Oct; 13(10):2291-305. PubMed ID: 12975311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paralog dispensability shapes homozygous deletion patterns in tumor genomes.
    De Kegel B; Ryan CJ
    Mol Syst Biol; 2023 Dec; 19(12):e11987. PubMed ID: 37963083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential genes shape cancer genomes through linear limitation of homozygous deletions.
    Pertesi M; Ekdahl L; Palm A; Johnsson E; Järvstråt L; Wihlborg AK; Nilsson B
    Commun Biol; 2019; 2():262. PubMed ID: 31341961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact.
    Wang L; Darling J; Zhang JS; Qian CP; Hartmann L; Conover C; Jenkins R; Smith DI
    Oncogene; 1998 Feb; 16(5):635-42. PubMed ID: 9482109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large common fragile site genes and cancer.
    Smith DI; McAvoy S; Zhu Y; Perez DS
    Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele-specific amplification in cancer revealed by SNP array analysis.
    LaFramboise T; Weir BA; Zhao X; Beroukhim R; Li C; Harrington D; Sellers WR; Meyerson M
    PLoS Comput Biol; 2005 Nov; 1(6):e65. PubMed ID: 16322765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.